MXPA03010259A - Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. - Google Patents
Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.Info
- Publication number
- MXPA03010259A MXPA03010259A MXPA03010259A MXPA03010259A MXPA03010259A MX PA03010259 A MXPA03010259 A MX PA03010259A MX PA03010259 A MXPA03010259 A MX PA03010259A MX PA03010259 A MXPA03010259 A MX PA03010259A MX PA03010259 A MXPA03010259 A MX PA03010259A
- Authority
- MX
- Mexico
- Prior art keywords
- thio
- novel
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/075—Benzo[b]pyran-2-ones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invencion se relaciona con nuevos compuestos de formula (I): (Ver Formula) en la cual: R1, R2 y R3 identicos o diferentes, representan, cada uno independientemente: un grupo (CI-C6) alquilo, un grupo piridinilo, o un grupo - CH2-NR4R5 en el cual R4 y R5 representan cada uno independientemente un atomo de hidrogeno, un grupo (C1-C4) alquilo o bien, R4 y R5 forman con el atomo de nitrogeno al cual estan unidos, un grupo pirrolidinilo, piperidinilo, hexahidroacetinilo, moriolinilo o piperazinilo, siempre y cuando por lo menos uno de los sustituyentes R1, R2 o R3 sea diferente del grupo (C1-C6) alquilo, asi como sus sales, solvatos e hidratos, particularmente farmaceuticamente aceptables; estos compuestos son utiles particularmente para el tratamiento de problemas de la circulacion venosa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0106236A FR2824559B1 (fr) | 2001-05-11 | 2001-05-11 | Nouveaux derives 5-thio-beta-xylopyronasides, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique |
| PCT/FR2002/001573 WO2002092614A1 (fr) | 2001-05-11 | 2002-05-07 | Nouveaux derives 5-thio-ss-d-xylopyranosides, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03010259A true MXPA03010259A (es) | 2004-03-10 |
Family
ID=8863165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010259A MXPA03010259A (es) | 2001-05-11 | 2002-05-07 | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6927209B2 (es) |
| EP (1) | EP1385858B1 (es) |
| JP (1) | JP2004534036A (es) |
| KR (1) | KR20030094351A (es) |
| CN (1) | CN1518557A (es) |
| AR (1) | AR035880A1 (es) |
| AT (1) | ATE323097T1 (es) |
| BG (1) | BG108347A (es) |
| BR (1) | BR0209102A (es) |
| CA (1) | CA2446763A1 (es) |
| CZ (1) | CZ20033021A3 (es) |
| DE (1) | DE60210595D1 (es) |
| EE (1) | EE200300548A (es) |
| FR (1) | FR2824559B1 (es) |
| HU (1) | HUP0304065A2 (es) |
| IL (1) | IL158587A0 (es) |
| MX (1) | MXPA03010259A (es) |
| NO (1) | NO20034985L (es) |
| PL (1) | PL369632A1 (es) |
| RU (1) | RU2003132704A (es) |
| SK (1) | SK13762003A3 (es) |
| WO (1) | WO2002092614A1 (es) |
| ZA (1) | ZA200308317B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2860234B1 (fr) * | 2003-09-25 | 2005-12-23 | Fournier Lab Sa | Nouveaux derives 666 du thioxylose |
| WO2006110726A2 (en) * | 2005-04-11 | 2006-10-19 | Glaxo Group Limited | Dosage formulations and methods of treatment and prevention |
| FR2903698B1 (fr) * | 2006-07-13 | 2009-01-30 | Fournier S A Sa Lab | Nouveaux derives de 5-thioxylopyranose. |
| FR2906247B1 (fr) * | 2006-09-27 | 2008-12-26 | Fournier S A Sa Lab | Nouveaux derives de 5-thioxylopyranose |
| FR2906248B1 (fr) * | 2006-09-27 | 2008-12-26 | Fournier S A Sa Lab | Nouveaux derives de 5-thioxylopyranose |
| WO2016054237A2 (en) * | 2014-10-03 | 2016-04-07 | Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | Poly (adp-ribose) polymerase 1 inhibitors structurally unrelated to nad |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE113956T1 (de) | 1989-09-22 | 1994-11-15 | Fournier Ind & Sante | Benzopyranon-beta-d-thioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung. |
-
2001
- 2001-05-11 FR FR0106236A patent/FR2824559B1/fr not_active Expired - Fee Related
-
2002
- 2002-05-06 US US10/139,908 patent/US6927209B2/en not_active Expired - Fee Related
- 2002-05-07 EP EP02738222A patent/EP1385858B1/fr not_active Expired - Lifetime
- 2002-05-07 PL PL02369632A patent/PL369632A1/xx not_active Application Discontinuation
- 2002-05-07 JP JP2002589497A patent/JP2004534036A/ja not_active Withdrawn
- 2002-05-07 AT AT02738222T patent/ATE323097T1/de not_active IP Right Cessation
- 2002-05-07 CA CA002446763A patent/CA2446763A1/fr not_active Abandoned
- 2002-05-07 MX MXPA03010259A patent/MXPA03010259A/es not_active Application Discontinuation
- 2002-05-07 DE DE60210595T patent/DE60210595D1/de not_active Expired - Fee Related
- 2002-05-07 CN CNA028097033A patent/CN1518557A/zh active Pending
- 2002-05-07 RU RU2003132704/04A patent/RU2003132704A/ru not_active Application Discontinuation
- 2002-05-07 HU HU0304065A patent/HUP0304065A2/hu unknown
- 2002-05-07 CZ CZ20033021A patent/CZ20033021A3/cs unknown
- 2002-05-07 SK SK1376-2003A patent/SK13762003A3/sk unknown
- 2002-05-07 KR KR10-2003-7013501A patent/KR20030094351A/ko not_active Withdrawn
- 2002-05-07 BR BR0209102-0A patent/BR0209102A/pt not_active IP Right Cessation
- 2002-05-07 IL IL15858702A patent/IL158587A0/xx unknown
- 2002-05-07 EE EEP200300548A patent/EE200300548A/xx unknown
- 2002-05-07 WO PCT/FR2002/001573 patent/WO2002092614A1/fr not_active Ceased
- 2002-05-08 AR ARP020101682A patent/AR035880A1/es unknown
-
2003
- 2003-10-24 ZA ZA200308317A patent/ZA200308317B/en unknown
- 2003-11-10 NO NO20034985A patent/NO20034985L/no not_active Application Discontinuation
- 2003-11-11 BG BG108347A patent/BG108347A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1518557A (zh) | 2004-08-04 |
| SK13762003A3 (sk) | 2004-04-06 |
| ZA200308317B (en) | 2005-03-11 |
| EP1385858A1 (fr) | 2004-02-04 |
| NO20034985D0 (no) | 2003-11-10 |
| HUP0304065A2 (hu) | 2004-04-28 |
| US6927209B2 (en) | 2005-08-09 |
| KR20030094351A (ko) | 2003-12-11 |
| ATE323097T1 (de) | 2006-04-15 |
| RU2003132704A (ru) | 2005-04-20 |
| DE60210595D1 (de) | 2006-05-24 |
| CA2446763A1 (fr) | 2002-11-21 |
| BG108347A (bg) | 2004-11-30 |
| US20020198193A1 (en) | 2002-12-26 |
| JP2004534036A (ja) | 2004-11-11 |
| EE200300548A (et) | 2004-02-16 |
| IL158587A0 (en) | 2004-05-12 |
| AR035880A1 (es) | 2004-07-21 |
| CZ20033021A3 (en) | 2004-04-14 |
| PL369632A1 (en) | 2005-05-02 |
| BR0209102A (pt) | 2004-07-13 |
| WO2002092614A1 (fr) | 2002-11-21 |
| FR2824559A1 (fr) | 2002-11-15 |
| NO20034985L (no) | 2003-11-10 |
| EP1385858B1 (fr) | 2006-04-12 |
| FR2824559B1 (fr) | 2004-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL366198A1 (en) | Novel compounds | |
| PL358281A1 (en) | Novel compounds | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
| ATE316083T1 (de) | Adamantanderivate | |
| MY136430A (en) | N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation | |
| SE9904652D0 (sv) | Novel Compounds | |
| DE60112609D1 (en) | Pyrazolopyridine | |
| SE0104140D0 (sv) | Novel Compounds | |
| MY134136A (en) | Novel compounds comprising jak3 kinase inhibitors | |
| SE9901875D0 (sv) | Novel compounds | |
| MY128924A (en) | Novel compounds | |
| MXPA05008690A (es) | Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| DE60112330D1 (en) | Pyrazolopyridinderivate | |
| SE0302139D0 (sv) | Novel compounds | |
| MXPA04001968A (es) | Agentes antidiabeticos. | |
| TW200604197A (en) | New compounds | |
| IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| SE0101038D0 (sv) | Novel compounds | |
| GB0120461D0 (en) | Novel compounds | |
| SE0303280D0 (sv) | Novel compounds | |
| AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
| MXPA02012426A (es) | Compuestos nuevos. | |
| DE60201074D1 (en) | Pyrazolopyridinderivate | |
| SE0202693D0 (sv) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |